Ledyard National Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.37M Sell
181,271
-1,359
-0.7% -$35.5K 0.35% 57
2026
Q1
$5.13M Buy
182,630
+4,005
+2% +$107K 0.44% 49
2025
Q4
$4.45M Sell
178,625
-1,591
-0.9% -$40.1K 0.38% 57
2025
Q3
$4.59M Sell
180,216
-8,621
-5% -$213K 0.41% 53
2025
Q2
$4.58M Sell
188,837
-10,739
-5% -$250K 0.43% 53
2025
Q1
$5.06M Sell
199,576
-5,547
-3% -$145K 0.5% 47
2024
Q4
$5.44M Sell
205,123
-42,815
-17% -$1.16M 0.51% 45
2024
Q3
$7.18M Sell
247,938
-31,000
-11% -$904K 0.66% 44
2024
Q2
$7.8M Sell
278,938
-75,556
-21% -$2.08M 0.76% 42
2024
Q1
$9.84M Sell
354,494
-23,238
-6% -$645K 0.95% 34
2023
Q4
$10.9M Buy
377,732
+13,266
+4% +$401K 1.12% 27
2023
Q3
$12.1M Buy
364,466
+2,230
+0.6% +$78.9K 1.38% 22
2023
Q2
$13.3M Buy
362,236
+3,065
+0.9% +$119K 1.45% 19
2023
Q1
$14.7M Sell
359,171
-3,145
-0.9% -$136K 1.68% 12
2022
Q4
$18.6M Sell
362,316
-1,907
-0.5% -$91.4K 2.18% 6
2022
Q3
$15.9M Buy
364,223
+1,654
+0.5% +$80.4K 2.07% 7
2022
Q2
$19M Buy
362,569
+2,824
+0.8% +$144K 2.3% 7
2022
Q1
$18.6M Buy
359,745
+8,286
+2% +$430K 1.86% 9
2021
Q4
$20.8M Sell
351,459
-8,606
-2% -$426K 1.99% 9
2021
Q3
$15.5M Sell
360,065
-4,023
-1% -$178K 1.6% 12
2021
Q2
$14.3M Buy
364,088
+852
+0.2% +$33.1K 1.46% 17
2021
Q1
$13.2M Buy
363,236
+7,431
+2% +$264K 1.42% 17
2020
Q4
$13.1M Sell
355,805
-17,078
-5% -$626K 1.5% 13
2020
Q3
$13M Sell
372,883
-5,862
-2% -$206K 1.64% 11
2020
Q2
$11.8M Buy
378,745
+9,860
+3% +$335K 1.57% 12
2020
Q1
$11.4M Sell
368,885
-27,987
-7% -$954K 1.74% 9
2019
Q4
$14.8M Buy
396,872
+450
+0.1% +$16K 1.79% 7
2019
Q3
$13.5M Sell
396,422
-8,666
-2% -$315K 1.78% 7
2019
Q2
$16.6M Sell
405,088
-8,054
-2% -$320K 2.23% 5
2019
Q1
$16.6M Sell
413,142
-28,398
-6% -$1.14M 2.2% 6
2018
Q4
$18.3M Buy
441,540
+89
+0% +$3.69K 2.41% 4
2018
Q3
$18.5M Sell
441,451
-4,053
-0.9% -$156K 2.1% 3
2018
Q2
$15.3M Buy
445,504
+3,772
+0.9% +$129K 1.83% 5
2018
Q1
$14.9M Buy
441,732
+7,253
+2% +$249K 1.81% 5
2017
Q4
$14.9M Sell
434,479
-564
-0.1% -$19.2K 1.81% 4
2017
Q3
$14.7M Buy
435,043
+94
+0% +$3.02K 1.96% 4
2017
Q2
$13.9M Sell
434,949
-999
-0.2% -$31.5K 1.99% 3
2017
Q1
$14.1M Buy
435,948
+52,571
+14% +$1.66M 2.12% 4
2016
Q4
$11.8M Sell
383,377
-13,995
-4% -$427K 2.1% 6
2016
Q3
$12.8M Buy
397,372
+28,927
+8% +$967K 2.28% 4
2016
Q2
$12.3M Sell
368,445
-26,890
-7% -$858K 2.22% 4
2016
Q1
$11.1M Buy
395,335
+10,464
+3% +$299K 1.97% 9
2015
Q4
$11.8M Buy
384,871
+656
+0.2% +$20.6K 2.12% 7
2015
Q3
$11.4M Sell
384,215
-1,948
-0.5% -$62.5K 2.2% 5
2015
Q2
$12.3M Sell
386,163
-6,728
-2% -$219K 2.15% 6
2015
Q1
$13M Sell
392,891
-3,214
-0.8% -$102K 2.33% 5
2014
Q4
$11.7M Sell
396,105
-1,951
-0.5% -$55.9K 2.16% 7
2014
Q3
$11.2M Buy
398,056
+1,388
+0.3% +$39K 2.08% 7
2014
Q2
$11.2M Buy
396,668
+2,674
+0.7% +$76.2K 1.87% 8
2014
Q1
$12M Buy
393,994
+3,169
+0.8% +$94.5K 2.04% 8
2013
Q4
$11.4M Sell
390,825
-3,749
-1% -$109K 1.89% 11
2013
Q3
$10.8M Buy
394,574
+2,890
+0.7% +$78.6K 1.89% 11
2013
Q2
$10.4M Buy
+391,684
New +$10.8M 1.93% 13

Other funds holding PFE

Ledyard National Bank's PFE Position: Q2 2026 in Review

Ledyard National Bank reduced its Pfizer (PFE) stake by 0.74% in Q2 2026, selling an estimated $35.5K and leaving 181,271 shares worth $4.37M. The position accounts for 0.35% of the portfolio, ranked #57.

Ledyard National Bank first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $20.8M in Q4 2021. 1,334 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Ledyard National Bank held 181,271 shares of Pfizer worth $4.37M as of Q2 2026.
  • Ledyard National Bank sold 1,359 Pfizer shares in Q2 2026, an estimated $35.5K.
  • Pfizer made up 0.35% of Ledyard National Bank's portfolio in Q2 2026, its #57 holding.
  • Ledyard National Bank first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Ledyard National Bank's Pfizer position peaked at $20.8M in Q4 2021.
  • 1,334 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ledyard National Bank's 13F filing for Q2 2026, filed 16 Jul 2026.